Company news
Shanghai Shyndec Pharmaceutical Co., Ltd. Class A (SSE:600420) news
Shanghai Shyndec Pharmaceutical Co., Ltd. Class A news releases on 6ix. Latest, Jul 18, 2025: Brief Announcement on Semi-annual Earnings for 2025
Press releases — page 2
Brief Announcement on Semi-annual Earnings for 2025
July 17, 2025
Announcement on Implementation of Dividend Distribution for 2024
July 9, 2025
Indicative Announcement on the Proposed Pre-Listing for Public Transfer of Equity Interests in a Controlling Subsidiary
June 30, 2025
Announcement on Wholly-owned Subsidiary Obtaining Notice of Approval for Marketing Application of Chemical APIs
June 27, 2025
Announcement on Resolutions of the 2024 Annual General Meeting
June 26, 2025
Announcement on the Voluntary Information Disclosure of the Holding Subsidiary's Drug Passing the Consistency Evaluation for Generic Drugs
June 20, 2025
Announcement on Progress in Accepting Drug Marketing Authorization by Holding Subsidiary
June 10, 2025
Announcement on Resolution of the 22nd Meeting of the 8th Board of Directors
June 5, 2025
Announcement on the Holding Subsidiary Obtaining the Approval Notice for Drug Supplementary Application
May 28, 2025
Announcement on Attending Collective Annual Report Performance Briefing of Listed Companies in Shanghai Jurisdiction in 2025
May 8, 2025
Report for Q1 2025
April 28, 2025